receipt-logo.png
Header-Donate-e1579794194299.png

Mesenchymal Stem Cells for Sanfilippo Syndrome

August 31, 2017
Engineering Mesenchymal Stem Cells (MSCS) to Produce Sulfamidase for Intrathecal Treatment of Sanfilippo Syndrome

Awardee: Jan Nolta, PhD, Director of UC Davis Stem Cell Program, University of California Davis, Institute for Regenerative Cures

Start Date: August 2017

Related Posts